Metabolic Explorer SA is a France-based biological chemistry company that specializes in the development of bioprocesses for the production of chemical compounds used in a range of products, such as textile fibers, paints, solvents, animal feed supplements and adhesives, among others. Metabolic Explorer SA offers chemicals, such as Glycolic acid, L-Methionine, MPG (1.2 Propanediol) and PDO (1.3 Propanediol).
The Company markets its products mainly for three families of industrialists: Manufacturers of agro-resources, Existing producers of chemical compounds and Manufacturers employing chemical compounds. In addition, the Company is engaged in the research and development works and runs its own laboratory to develop micro-organisms..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 0 |
| Three Month Average Volume | 0 |
| High Low | |
| Fifty-Two Week High | 0.979 EUR |
| Fifty-Two Week Low | 0.0503 EUR |
| Fifty-Two Week High Date | 01 Nov 2023 |
| Fifty-Two Week Low Date | 02 May 2024 |
| Price and Volume | |
| Current Price | 0.1214 EUR |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -6.51% |
| Thirteen Week Relative Price Change | 4.60% |
| Twenty-Six Week Relative Price Change | -65.91% |
| Fifty-Two Week Relative Price Change | -83.45% |
| Year-to-Date Relative Price Change | -69.13% |
| Price Change | |
| One Day Price Change | 0.00% |
| Thirteen Week Price Change | 0.00% |
| Twenty-Six Week Price Change | -67.23% |
| Five Day Price Change | 0.00% |
| Fifty-Two Week Price Change | -82.66% |
| Year-to-Date Price Change | -68.71% |
| Month-to-Date Price Change | 0.00% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 2.31928 EUR |
| Book Value Per Share (Most Recent Quarter) | 1.86834 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | 1.99002 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | 1.57736 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.71136 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 5.07034 EUR |
| Revenue Per Share (Trailing Twelve Months) | 3.22924 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 0 EUR |
| Dividend Per Share (Trailing Twelve Months) | 0 EUR |
| Dividend Per Share (5 Year) | 0 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -1.13744 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.95368 EUR |
| Normalized (Last Fiscal Year) | -1.13744 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -1.13744 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.95368 EUR |
| Including Extraordinary Items (Last Fiscal Year) | -1.13744 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | -0.95368 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.30218 EUR |
| Cash Per Share (Most Recent Quarter) | 0.94094 EUR |
| Cash Flow Per Share (Last Fiscal Year) | -0.94035 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | -0.78838 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | -1.05145 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -32 |
| Cash Flow Revenue (Trailing Twelve Months) | -33 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -29.65% |
| Pretax Margin (Last Fiscal Year) | -21.11% |
| Pretax Margin (5 Year) | 0.16% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | -0.63% |
| Gross Margin (Trailing Twelve Months) | -4.97% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -19.31% |
| Operating Margin (Trailing Twelve Months) | -27.26% |
| Operating Margin (5 Year) | 1.56% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -22.43% |
| Net Profit Margin (Trailing Twelve Months) | -29.64% |
| Net Profit Margin (5 Year) | 1.32% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 3.91% |
| Tangible Book Value (5 Year) | 23.93% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -46.53% |
| Revenue Growth (3 Year) | 123.77% |
| Revenue Change (Trailing Twelve Months) | -36.56% |
| Revenue Per Share Growth | 96.97% |
| Revenue Growth (5 Year) | 765.10% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 88.72% |
| Total Debt (5 Year) | 50.98% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 32.85% |
| EPS Change (Trailing Twelve Months) | -138.07% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 0 |
| Price to Tangible Book (Most Recent Quarter) | 0 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 57.9M |
| Net Debt (Last Fiscal Year) | 34.4M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 3 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 2 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | 0.00% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 0 |
| Price to Book (Most Recent Quarter) | 0 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 21 |
| Long Term Debt to Equity (Most Recent Quarter) | 92 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -54,674,000 |
| Free Cash Flow (Trailing Twelve Months) | -54,200,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -11 |
| Net Interest Coverage (Trailing Twelve Months) | -11 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 46 |
| Total Debt to Equity (Most Recent Quarter) | 111 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -21.39% |
| Return on Assets (Trailing Twelve Months) | -18.79% |
| Return on Assets (5 Year) | 0.88% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -39.24% |
| Return on Equity (Trailing Twelve Months) | -42.82% |
| Return on Equity (5 Year) | 2.56% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -31.14% |
| Return on Investment (Trailing Twelve Months) | -27.12% |
| Return on Investment (5 Year) | 1.25% |